Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer

Risk of hypogonadism in male survivors of childhood cancer

Nature Reviews Endocrinology volume 6, pages 129–130 (2010)Cite this article

Subjects

New results suggest that male survivors of childhood cancer are at an increased risk of developing low testosterone levels in adult life. Are the data convincing enough to recommend screening for hypogonadism in men treated with chemotherapy and radiotherapy during childhood?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Romerius, P. et al. Hypogonadism risk in men treated for childhood cancer. J. Clin. Endocrinol. Metab. 94, 4180–4186 (2009).

    Article  CAS  PubMed  Google Scholar 

  2. Greenfield, D. M. et al. Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study. J. Clin. Endocrinol. Metab. 92, 3476–3482 (2007).

    Article  CAS  PubMed  Google Scholar 

  3. Bremner, W. J., Vitiello, M. V. & Prinz, P. N. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J. Clin. Endocrinol. Metab. 56, 1278–1281 (1983).

    Article  CAS  PubMed  Google Scholar 

  4. Spratt, D. I. et al. Neuroendocrine-gonadal axis in men: frequent sampling of, LH, FSH, and testosterone. Am. J. Physiol. 254, E658–E666 (1988).

    CAS  PubMed  Google Scholar 

  5. Swerdloff, R. S. et al. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J. Clin. Endocrinol. Metab. 85, 4500–4510 (2000).

    CAS  PubMed  Google Scholar 

  6. Howell, S. J. et al. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy. Clin. Endocrinol. (Oxf.) 55, 315–324 (2001).

    Article  CAS  Google Scholar 

  7. Bhasin, S. et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 91, 1995–2010 (2006).

    Article  CAS  PubMed  Google Scholar 

  8. Araujo, A. B. et al. Prevalence of symptomatic androgen deficiency. J. Clin. Endocrinol. Metab. 92, 4241–4247 (2007).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland

    Tomas Ahern & Frances J. Hayes

Authors
  1. Tomas Ahern
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frances J. Hayes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frances J. Hayes.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahern, T., Hayes, F. Risk of hypogonadism in male survivors of childhood cancer. Nat Rev Endocrinol 6, 129–130 (2010). https://doi.org/10.1038/nrendo.2009.277

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2009.277

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer